Xiaoyun Lu – författare

Kinase Targets and Drug Discovery covers the critical role of kinases as regulators of cellular functions and their implications in a range of diseases, from cancers to cardiovascular disorders and inflammatory conditions. Readers will explore foundational concepts on the functions of kinases, the role of kinase inhibitors in disease therapy, and challenges faced. The second section focuses on innovative strategies in kinase drug discovery, covering screening and computational approaches, along with the development of covalent, macrocyclic, allosteric inhibitors, and kinase degraders. Final sections examine clinical applications, detailing how kinase inhibition can be harnessed for cancer therapies, non-oncologic diseases, and even non-catalytic functions.This book will serve as an indispensable resource for pharmacologists, medicinal chemists, and researchers in both academia and industry. By bridging the gap between foundational research and clinical application, it equips professionals with the latest insights and practical approaches to advance their understanding to contribute meaningfully to the evolving landscape of drug discovery.Provides a comprehensive overview of kinase biology and its therapeutic implications across various diseasesExplores innovative strategies for kinase inhibitor discovery and developmentIncludes insights into cutting-edge technologies such as AI and novel therapeutic modalitiesCovers practical approaches for researchers in academia and industry to enhance drug discovery effortsServes as an essential resource for understanding the clinical applications of kinase inhibitors in modern therapeutics

Kinase Targets and Drug Discovery covers the critical role of kinases as regulators of cellular functions and their implications in a range of diseases, from cancers to cardiovascular disorders and inflammatory conditions. Readers will explore foundational concepts on the functions of kinases, the role of kinase inhibitors in disease therapy, and challenges faced. The second section focuses on innovative strategies in kinase drug discovery, covering screening and computational approaches, along with the development of covalent, macrocyclic, allosteric inhibitors, and kinase degraders. Final sections examine clinical applications, detailing how kinase inhibition can be harnessed for cancer therapies, non-oncologic diseases, and even non-catalytic functions.This book will serve as an indispensable resource for pharmacologists, medicinal chemists, and researchers in both academia and industry. By bridging the gap between foundational research and clinical application, it equips professionals with the latest insights and practical approaches to advance their understanding to contribute meaningfully to the evolving landscape of drug discovery. - Provides a comprehensive overview of kinase biology and its therapeutic implications across various diseases- Explores innovative strategies for kinase inhibitor discovery and development- Includes insights into cutting-edge technologies such as AI and novel therapeutic modalities- Covers practical approaches for researchers in academia and industry to enhance drug discovery efforts- Serves as an essential resource for understanding the clinical applications of kinase inhibitors in modern therapeutics